Arcus Biosciences, Inc. SEC filings RCUS

Arcus Biosciences, Inc. has 609 filings in SEC EDGAR's recent list, going back to Dec 15, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Arcus Biosciences, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Other events
Oct 23, 2026 Oct 21, 2026
424B5 Prospectus supplement Oct 22, 2026 —
424B5 Prospectus supplement Oct 21, 2026 —
8-K Current report
Results of operations
Oct 21, 2026 Oct 21, 2026
8-K Current report
Other events
Oct 20, 2026 Oct 20, 2026
CT ORDER Filing Sep 28, 2026 —
4 Insider transaction Aug 24, 2026 Aug 21, 2026
144 Notice of proposed sale Aug 21, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 7, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 22, 2026 —
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 1, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 12, 2026 Dec 16, 2025
4 Insider transaction May 12, 2026 May 11, 2026
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 6, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
144 Notice of proposed sale Apr 23, 2026 —
ARS Annual report to shareholders Apr 21, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 21, 2026 —
DEF 14A Proxy statement Apr 21, 2026 Jun 11, 2026
8-K Current report
Other events
Apr 20, 2026 Apr 20, 2026
144 Notice of proposed sale Apr 8, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
8-K Current report
Officer or director change
Mar 23, 2026 Mar 17, 2026
S-3ASR Automatic shelf registration Feb 25, 2026 —
S-8 Employee stock plan registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 9, 2026 Jan 8, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2026 —
4 Insider transaction Jan 7, 2026 Jan 5, 2026
144 Notice of proposed sale Jan 5, 2026 —
4 Insider transaction Jan 2, 2026 Dec 31, 2025
4 Insider transaction Jan 2, 2026 Dec 30, 2025
144 Notice of proposed sale Dec 31, 2025 —
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
144 Notice of proposed sale Dec 18, 2025 —
8-K Current report
Material agreement, New debt
Dec 18, 2025 Dec 18, 2025
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
8-K Current report
Other events
Dec 12, 2025 Dec 12, 2025
4 Insider transaction Dec 5, 2025 Dec 4, 2025
144 Notice of proposed sale Dec 4, 2025 —
4 Insider transaction Dec 1, 2025 Nov 26, 2025
144 Notice of proposed sale Nov 26, 2025 —
4 Insider transaction Nov 26, 2025 Nov 26, 2025
144 Notice of proposed sale Nov 26, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 12, 2025 Nov 7, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 5, 2025 —
4 Insider transaction Nov 3, 2025 Oct 30, 2025
8-K Current report
Other events
Nov 3, 2025 Oct 30, 2025
424B5 Prospectus supplement Oct 31, 2025 —
144 Notice of proposed sale Oct 30, 2025 —
424B5 Prospectus supplement Oct 30, 2025 —
4 Insider transaction Oct 30, 2025 Oct 28, 2025
4 Insider transaction Oct 29, 2025 Oct 28, 2025
144/A Filing Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
8-K Current report
Other events
Oct 14, 2025 Oct 12, 2025
4 Insider transaction Oct 8, 2025 Oct 6, 2025
144 Notice of proposed sale Oct 6, 2025 —
8-K Current report
Other events
Oct 6, 2025 Oct 6, 2025
4 Insider transaction Sep 30, 2025 Sep 29, 2025
144 Notice of proposed sale Sep 29, 2025 —
4 Insider transaction Sep 5, 2025 Sep 5, 2025
144 Notice of proposed sale Sep 5, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 15, 2025 —
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
8-K Current report
Shareholder vote results, Other events
Jun 12, 2025 Jun 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2025 Jun 1, 2025
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Jun 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 5, 2025 —
4 Insider transaction Feb 27, 2025 Feb 27, 2025
4 Insider transaction Feb 27, 2025 Feb 27, 2025
S-8 Employee stock plan registration Feb 25, 2025 —
10-K Annual report Feb 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 20, 2025 —
4 Insider transaction Feb 20, 2025 Feb 18, 2025
8-K Current report
Other events
Feb 19, 2025 Feb 18, 2025
424B5 Prospectus supplement Feb 18, 2025 —
8-K Current report
Results of operations, Other events
Feb 18, 2025 Feb 15, 2025
4 Insider transaction Feb 11, 2025 Feb 10, 2025
3 Initial insider ownership Feb 11, 2025 Jan 31, 2025
3 Initial insider ownership Feb 10, 2025 Feb 6, 2025
8-K Current report
Officer or director change
Feb 6, 2025 Feb 6, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
8-K Current report
Officer or director change
Jan 21, 2025 Jan 16, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
144 Notice of proposed sale Dec 31, 2024 —
4 Insider transaction Dec 20, 2024 Dec 19, 2024
SC 13D/A Amended ownership over 5% (active) Dec 17, 2024 —
4 Insider transaction Dec 17, 2024 Dec 15, 2024
4 Insider transaction Dec 17, 2024 Dec 15, 2024
4 Insider transaction Dec 17, 2024 Dec 15, 2024
4 Insider transaction Dec 17, 2024 Dec 15, 2024
4 Insider transaction Dec 17, 2024 Dec 15, 2024
4 Insider transaction Dec 17, 2024 Dec 15, 2024
4 Insider transaction Dec 17, 2024 Dec 15, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 24, 2024 Oct 24, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 23, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 17, 2024 —
4 Insider transaction Sep 17, 2024 Sep 15, 2024
4 Insider transaction Sep 17, 2024 Sep 15, 2024
8-K Current report
Material agreement, New debt
Aug 27, 2024 Aug 27, 2024
4 Insider transaction Aug 15, 2024 Aug 13, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Jun 18, 2024 Jun 15, 2024
4 Insider transaction Jun 18, 2024 Jun 15, 2024
4 Insider transaction Jun 18, 2024 Jun 15, 2024
4 Insider transaction Jun 18, 2024 Jun 15, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
8-K Current report
Shareholder vote results, Other events
Jun 6, 2024 Jun 6, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2024 Jun 2, 2024
8-K Current report
Other events
May 23, 2024 May 23, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Jun 6, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
144 Notice of proposed sale Mar 27, 2024 —
4 Insider transaction Mar 20, 2024 Mar 18, 2024
144 Notice of proposed sale Mar 15, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RCUS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hayward, CA
SEC filer status
Large accelerated filer
SEC CIK
1724521

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.